RATIONALE DIAGNOSTIK UND THERAPIE DER OBSTRUKTIVEN ATEMWEGSKRANKHEITEN IN DER PRAXIS = DIAGNOSTIC RATIONNEL ET TRAITEMENT DES OBSTRUCTIONS DES VOIES RESPIRATOIRES EN PRATIQUEHELLMANN K.1979; THERAPIEWOCHE; DEU; DA. 1979; VOL. 29; NO 28; PP. 4572-4578; (5 P.); BIBL. 8 REF.Article

EICHUNG DER TRIAS-ZEITSKALA = ETALONNAGE DE L'ECHELLE DES TEMPS DU TRIASHELLMANN K.1978; FORSCHUNGSBER. UNIV. HEIDELBERG; DEU; DA. 1978; VOL. 1975; PP. 495Article

EFFECT OF ICRF 159 ON IMMUNE RESPONSES = EFFET DE L'ICRF 159 SUR LES REPONSES IMMUNESHELLMANN K.1972; PROC. R. SOC. MED.; G.B.; DA. 1972; VOL. 65; NO 3; PP. 264-265; BIBL. 12REF.Serial Issue

Cardioprotection by dexrazoxane (Cardioxane; ICRF 187) : progress in supportive careHELLMANN, K.Supportive care in cancer. 1996, Vol 4, Num 4, pp 305-307, issn 0941-4355Article

Strategies for the integration of INTRON A (interferon Alfa-2b) into the treatment of hematological malignancies: proceedings/Symposium on INTRON A: 3rd. international conference on malignant lymphoma, Lugano, June 1987HELLMANN, K.Cancer treatment reviews. 1988, Vol 15, issn 0305-7372, 65 p., suppl. AConference Proceedings

HISTAMINE RECEPTOR ANTAGONISM AND ANTI-TUMOUR ACTIVITY = ANTAGONISME DU RECEPTEUR DE L'HISTAMINE ET ACTIVITE ANTITUMORALECOLLINS M; HELLMANN K.1982; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1982; VOL. 46; NO 5; PP. 817-820; BIBL. 18 REF.; GRAPHArticle

Proceedings Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experience. Satellite symposium: 4th European conference on clinical oncology, Madrid, Spain, 2 November 1987HELLMANN, K.Cancer treatment reviews. 1988, Vol 15, issn 0305-7372, 44 p., suppl. BConference Proceedings

SYNERGISM OF ICRF 159 AND RADIOTHERAPY IN TREATMENT OF EXPERIMENTAL TUMORSHELLMANN K; MURKIN GE.1974; CANCER; U.S.A.; DA. 1974; VOL. 34; NO 4; PP. 1033-1039; BIBL. 12REF.Article

PROCEEDINGS OF THE GERMAN CANCER SOCIETY (CLINICAL ONCOLOGY SECTION) AND BRISTOL-MYERS GMBH SYMPOSIUM ON ETOPOSIDE (VP-16), CURRENT STATUS AND NEW DEVELOPMENTS, FRANKFURT, 21-22 MAY 1981HELLMANN K ED; HILGARD P ED.1982; CANCER TREAT. REV.; ISSN 0305-7372; GBR; DA. 1982; SUPPL. A; 143 P.; BIBL. DISSEM.Conference Paper

THE EFFECTS OF AN ANTIMETASTATIC AGENT, ( +OU- )-1,2-BIS (3,5-DIOXOPIPERAZIN-1-YL) PROPANE (ICRF 159), ON PLATELET BEHAVIOR = EFFET D'UN AGENT ANTIMETASTATIQUE, LE ( +OU- ) BIS-1,2 (DIOXO-3,5 PIPERAZINE-YL-1) PROPANE, (ICRF 159) SUR LE COMPORTEMENT DES PLAQUETTESATHERTON A; BUSFIELD D; HELLMANN K et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 4; PP. 953-957; BIBL. 14REF.Article

HISTOLOGICAL ANALYSIS OF THE ANTIMETASTATIC EFFECT OF ( +OU- )-1,2-BIS (3,5-DIOXOPIPERAZIN-1-YL)PROPANE = ANALYSE HISTOLOGIQUE DE L'EFFET ANTIMETASTATIQUE DU ( +OU- ) BIS-1,2(DIOXO-3,5 PIPERAZIN-YL-1) PROPANE (BDPP)SALSBURY AJ; BURRAGE K; HELLMANN K et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 4; PP. 843-849; BIBL. 16 REF.Article

Entwicklung der Schraubtechnik = Evolution de la technologie des assemblages filetés = Development in the screwing technologyHELLMANN, K.- H.VDI-Z. 1989, Vol 131, Num 5, pp 89-93, issn 0042-1766Article

Rohstoffsicherung in der Regionalplanung am Beispiel des Raumordnungsverbandes Rhein-Neckar, der Region Unterer Necker und der Region Rheinpfalz = Garantie de matières premières dans la planification régionale sur l'exemple de l'association d'aménagement de l'espace Rhin-Neckar, de la région du Bas Neckar et de celle de Rhénanie-PalatinatHELLMANN, K. N.1986, 130 p.Book

A COMPARISON OF RESULTS OBTAINED BETWEEN TWO METHODS OF DETECTING THE EXISTENCE OF CIRCADIAN RHYTHMICITY IN CELL DIVISION: AN AUTORADIOGRAPHICAL AND A BIOCHEMICAL APPROACHCHALLONER D; SIMNET JD; HELLMANN K et al.1981; J. CELL SCI.; ISSN 0021-9533; GBR; DA. 1981; VOL. 47; PP. 249-265; BIBL. 17 REF.Article

COMBINATION OF RADIATION AND RAZOXANE (ICRF 159) IN VIVO.HELLMANN K; GRIMSHAW MB; HUTCHINSON GE et al.1978; INTERACTION J. RAD. ONCOL. BIOL. PHYS.; U.S.A.; DA. 1978; VOL. 4; NO 1-2; PP. 109-113; BIBL. 23 REF.; (INTERACTION RADIAT. ANTITUMOR DRUGS. STANFORD CADE MEM. SYMP.; LONDON; 1976)Conference Paper

SYMPOSIUM ON VINDESINEHELLMANN K ED; CARTER SK ED.1980; CANCER TREAT. REV.; ISSN 0305-7372; GBR; DA. 1980; VOL. 7; NO 3; SUPPL.; 93 P.; BIBL. DISSEM.Conference Paper

CUMULATIVE CYTOSTATIC EFFECT OF ICRF159HALLOWES RC; WEST DG; HELLMANN K et al.1974; NATURE; G.B.; DA. 1974; VOL. 247; NO 5441; PP. 487-490; BIBL. 14REF.Article

STRAHLENTHERAPIE UND ICRF 159 (NSC 129943) IN DER BEHANDLUNG INOPERABLER WEICHTEILSARKOME = LA RADIOTHERAPIE ET L'ICRF 159 (NSC 129943) DANS LE TRAITEMENT DES SARCOMES INOPERABLES DES PARTIES MOLLESRHOMBERG W; HELLMANN K; RYALL RDH et al.1974; DTSCHE MED. WSCHR.; DTSCH.; DA. 1974; VOL. 99; NO 48; PP. 2438-2442; ABS. ANGL.; BIBL. 20 REF.Article

RAZOXANE PENETRATION INTO THE CEREBROSPINAL FLUID OF RATSGREIG N; FU XIAO CHANG; HELLMANN K et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 2; PP. 251-252; BIBL. 6 REF.Article

THE NEW DEVELOPMENTS OF CANCER TREATMENTHELLMANN K ED; CARTER SK ED.1980; CANCER TREAT. REV.; ISSN 0305-7372; GBR; DA. 1980; VOL. 7; NO 4; 100 P.; BIBL. DISSEM.Conference Paper

COMBINED TREATMENT OF SOFT TISSUE AND OSTEOSARCOMAS BY RADIATION AND ICRF 159RYALL RDH; HANHAM IWF; NEWTON KA et al.1974; CANCER; U.S.A.; DA. 1974; VOL. 34; NO 4; PP. 1040-1045; BIBL. 16REF.Article

Proceedings of a symposium on ifosfamide (Mitoxana^®; Holoxan^®) and mesna (Uromitexan^®), held at the De Vere Hotel, Coventry, U.K., 16-18 March 1983 = Comptes-rendus d'un symposium sur l'ifosfamide (Mitoxana; Holoxan) et le mesna (Uromitexan) tenu à l'hôtel De Vere, Coventry, Royaume Uni, 16-18 mars 1983HELLMANN, K.Cancer treatment reviews. 1983, Vol 10, issn 0305-7372, 192 p., suppl. AConference Proceedings

International symposium on modification of drug resistance, Aachen, FRG, 23 June 1990HELLMANN, K; OSIEKA, R.Cancer treatment reviews. 1990, Vol 17, issn 0305-7372, 89 p., SUPAConference Proceedings

Paraplatin (carboplatin) current status and future prospects: proceedings/3rd European conference on clinical oncologyCARTER, S. K; HELLMANN, K.Cancer treatment reviews. 1985, Vol 12, issn 0305-7372, 152 p., suppl. AConference Proceedings

Recent advances in Intron A (Interferon alfa-2B) in oncology: proceedings/ symposium on Intron A (Interferon alfa-2B): 3rd. European conference on clinical oncology, Stockholm, June 19, 1985HELLMANN, K; TURNBULL, C. P.Cancer treatment reviews. 1985, Vol 12, issn 0305-7372, 70 p., suppl. BConference Proceedings